Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases

Long-term survival of patients with stage IV esophageal cancer is rare, with less than 5% surviving 5 years (1). Only palliative chemotherapy and supportive measures are recommended by current National Comprehensive Cancer Network guidelines (2)